Skip to main content

Par 605 (Lamotrigine Extended-Release 300 mg)

Pill with imprint Par 605 is Gray, Round and has been identified as Lamotrigine Extended-Release 300 mg. It is supplied by Par Pharmaceutical Inc.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Par 605

Lamotrigine extended-release 300 mg Par 605

Lamotrigine Extended-Release

Par 605
300 mg
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Inc.
National Drug Code (NDC)
Inactive Ingredients
ferrosoferric oxide, methacrylic acid, hypromelloses, silicon dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.